Earnings Estimates for Core Laboratories Revised Downward by Zacks Research

On March 26, 2025, Zacks Research released a report stating that it has reduced its earnings per share (EPS) estimates for Core Laboratories Inc. (NYSE:CLB). Analyst T. Saha now estimates that the oil and gas company will earn approximately $0.21 per share for the upcoming second quarter, a decrease from the previous forecast of $0.25. The consensus for Core Laboratories’ full-year earnings remains at $0.96 per share.

Additionally, Zacks provided projections for Core Laboratories' future earnings: they predict $0.18 EPS for the first quarter of 2026, $0.34 EPS for the fourth quarter of 2026, and $1.28 EPS for the full year of 2027.

Core Laboratories recently reported its earnings on January 29, where it showed an EPS of $0.23 for the quarter, meeting analysts’ expectations. The company has noted a net margin of 5.99% and a return on equity of 16.24%. These figures indicate how effectively Core Laboratories is managing its resources to generate profits.

In separate news, Citigroup adjusted its rating for Core Laboratories from "sell" to "neutral". The investment firm also raised its price target for the stock from $15.00 to $16.00, suggesting a potential for growth. Currently, one analyst has a "sell" rating on the stock, while four analysts recommend holding onto it. The average rating stands at a "Hold" with a target price of approximately $17.50.

Core Laboratories Stock Performance

As of Friday, Core Laboratories' stock opened at $15.47. The stock's 50-day moving average is $16.52, and its 200-day moving average is $18.10. Over the past year, the stock has fluctuated, reaching a low of $12.95 and a high of $25.13. With a market capitalization of approximately $724.41 million, the stock carries a price-to-earnings ratio of 23.44, a PEG ratio of 0.99, and a beta of 2.38. The company also maintains a debt-to-equity ratio of 0.49, a current ratio of 2.32, and a quick ratio of 1.71.

Institutional Investor Activity

Recent activity from institutional investors shows significant movement regarding Core Laboratories. Assetmark Inc. initiated a new position in the company, valued at $26,000, in the fourth quarter. Smartleaf Asset Management LLC boosted its stake by 173.8%, owning 2,037 shares worth $35,000 after acquiring an additional 1,293 shares. Nisa Investment Advisors LLC raised its position dramatically by 2,688.5%, now holding 2,426 shares valued at approximately $42,000. Furthermore, Tower Research Capital LLC expanded its holdings by 843.7%, increasing its total to 3,284 shares, worth about $57,000. Finally, BNP Paribas Financial Markets purchased a new investment in Core Laboratories valued around $123,000.

In total, institutional and hedge fund ownership accounts for a remarkable 97.81% of Core Laboratories’ stock, reflecting strong confidence from large investors.

Core Laboratories Dividend Information

The company also announced a quarterly dividend recently, which was distributed on March 3. Shareholders recorded on February 10 received a dividend of $0.01 per share, marking an annualized total of $0.04 and representing a yield of 0.26%. The ex-dividend date was also February 10, with the current payout ratio for Core Laboratories standing at 6.06%.

About Core Laboratories

Core Laboratories Inc. focuses on providing specialized services related to reservoir description and production enhancement within the oil and gas industry, both in the United States and internationally. The company operates through two primary segments: Reservoir Description and Production Enhancement. The Reservoir Description segment is dedicated to characterizing petroleum reservoir rock and fluid samples, aiding clients in improving crude oil and gas recovery from their reserves.

earnings, estimates, stock